HCPLive Conference Information: AAN 2011

Article

Scheduling, session topics, keynote speakers, and other information for physicians planning to attend AAN 2011.

The 63rd Annual Meeting of the American Academy of Neurology

When: April 9-16Where: Hawaiian Convention Center, Honolulu, HI

This year’s Annual Meeting of the American Academy of Neurology will feature more than 2,500 abstracts, more in-depth subspecialty sessions than in years past, a new physician leadership program, expanded hands-on neurology skills pavilions, and much more. Attendees will be able to select from four tracks: Aging/Dementia/Degenerative Disease, Cerebrovascular Disease, Child Neurlogy, or Movement Disorders.

Visit the main AAN 2011 website to learn more about the meeting, access a complete session schedule, and register to attend.

Download the AAN 2011 conference Registration and Advance Program, as well as the Scientific Abstracts Listing.

Plenary Sessions

Tuesday, April 12

Stefan M. Pulst, MD, FAAN, Chair, Science Committee, will moderate the Presidential Plenary Session, which will feature the Academy’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers will speak on some of the most significant findings in neurology in 2011.

Lectures include:

Presidential Lecture:

The Treatment of Neurological Disease: A Progress Report

Robert C. Griggs, MD, FAAN — AAN President,

University of Rochester, Rochester, NY

Robert Wartenberg Lecture:

Multiple Sclerosis: What’s in Store for Our Patients?

Stephen L. Hauser, MD — University of California, San Francisco, CA

Houston H. Merritt Lecture:

Spontaneous Activity in Muscle

Jasper R. Daube, MD, FAAN — Mayo Clinic, Rochester, MN

Tuesday, April 12

Raymond P. Roos, MD, FAAN, Member, Science Committee, will moderate the Hot Topics Plenary Session. This session highlights important and interesting abstracts presented at subspecialty meetings leading up to the Annual Meeting that are not on the program but should be heard by a wide audience at the Annual Meeting. Topics are selected by the AAN Science Committee and AAN Scientific Program Subcommittee.

Wednesday, April 13

Carlayne E. Jackson, MD, FAAN, Member, Science Committee, will moderate the Contemporary Clinical Issues and Case Studies Plenary Session. This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. In addition to the Contemporary Clinical Issues discussion, a case study format addresses topics of interest.

Thursday, April 14

Stefan M. Pulst, MD, FAAN, Chair, Science Committee, will moderate the Frontiers in Clinical Neuroscience Plenary Session. This session focuses on translational research related to clinical issues of importance. Four physician-scientists will outline their recent research findings, along with the clinical implications:

Neurodegeneration: Models and Mechanisms

Serge Przedborski, MD, PhD

Columbia University, New York, NY

Neurexins and Neuroligins: From Synaptic Cell Adhesions to Autism

Thomas C. Sudhof, MD

Stanford University, Palo Alto, CA

Optogenetics: Development and Application

Karl Diesseroth, MD, PhD

Stanford University, Palo Alto, CA

Coding and Decoding Pathogenic Ion Channels in Epilepsy

Jeffrey Noebels, MD, PhD

Baylor College of Medicine, Houston, TX

Exhibit Hall

Exhibit hall hours, which are new for 2011, are as follows:

  • Monday, April 11, 2011: 4:30pm - 6:30pm
  • Tuesday, April 12, 2011: 7:00am - 9:00am and 10:30am - 2:30pm
  • Wednesday, April 13, 2011: 7:00am - 9:00am and 10:30am - 2:30pm
  • Thursday, April 14, 2011: 7:00am - 9:00am and 10:30am - 2:30pm
Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.